Ramalho KM et al., 2020-11-16: Three-arm randomised trial in 75 patients with recurrent herpes labialis comparing methylene blue photodynamic therapy, topical acyclovir and the combination: no significant difference in healing time or pain between groups; on day 1 photodynamic therapy gave better results for oedema and tingling, and the acyclovir group showed a smaller reduction in lesion size than the acyclovir-plus-photodynamic-therapy group.
There was no significant difference in healing time and pain between groups.
Abstract
Ramalho KM et al., 2020-11-16: Three-arm randomised trial in 75 patients with recurrent herpes labialis comparing methylene blue photodynamic therapy, topical acyclovir and the combination: no significant difference in healing time or pain between groups; on day 1 photodynamic therapy gave better results for oedema and tingling, and the acyclovir group showed a smaller reduction in lesion size than the acyclovir-plus-photodynamic-therapy group. Study type: randomised controlled clinical trial, three groups of 25. Country: Brazil (Universidade de Sao Paulo). PDT arm: low-power laser 660 nm, 40 mW, 120 J/cm2, 4.8 J, 120 s per point with 0.005% methylene blue; comparators 5% topical acyclovir and PDT+acyclovir. Outcome: lesion size, healing time, self-reported pain/tingling/oedema, daily until healing. Funder/COI not stated in retrieved abstract record. Bearing: a genuine null result for the dermatological use most often claimed. Study type: randomized trial.
